Basal Cell Carcinoma
Imaging Using FCM Analysis Aids Surgical Removal of Tumors From Eyelid
December 30, 2016Current study evaluated reflectance mode, horizontal scanning for removal of eyelid basal cell carcinoma.
Topical Skin Creams Are Effective in Treatment of Superficial Basal Cell Carcinoma
June 24, 2016Results from a clinical trial indicate that 2 topical creams compared favorably to photodynamic therapy for primary, low-risk superficial basal cell carcinoma.
Proteins May Be Biomarkers for Ominous Change in Basal Cell Carcinoma
May 09, 2016Aggressive basal cell skin cancers have higher levels of both EZH2 and Ki67, suggesting these proteins have potential to serve as biomarkers for when basal cell carcinoma has become dangerous.
Periocular basal cell carcinomas exhibit fast growth rates
April 14, 2015Faster growth rate for basal cell carcinomas is seen in association with recurrent tumors, larger tumors at presentation, and male sex.
Basal-cell carcinoma targeted by new deoxyribozyme drug
May 22, 2013A new class of drugs targeting the genetic material of skin cancer has been successfully tested in humans for the first time. This opens the way to new treatments for a range of conditions from skin cancers to eye diseases.
The significance of stress: Early childhood experiences can influence recurrence of BCC
August 24, 2012New research shows that poor parental relationships can have a lasting impact on cancer risk.
Basal cell carcinoma viewed as a chronic disease for some
August 22, 2012Because people who have had multiple bouts of basal cell carcinoma always risk recurrence, the disease can be considered chronic for such patients.
_SkinCancer_Sc2_SkinCube_03.jpg&c=1&h=100&w=144 "Prior Basal Cell Carcinoma Is Main Predictor of Future BCC")
Prior Basal Cell Carcinoma Is Main Predictor of Future BCC
July 31, 2012Sunburn, baseline sun exposure, and sun protective measures do not independently predict risk of BCC.
Basal cell carcinoma risk down with caffeine intake
July 02, 2012An inverse association exists between caffeine from all dietary sources and the risk of basal cell carcinoma.
ONA Articles
- Sexual Dysfunction in Women With Cancer: A Review of Available Interventions
- Osteoporosis Medication Improves Bone Health in ADT-Treated Prostate Cancer
- Inotuzumab Ozogamicin Granted FDA Approval for Acute Lymphoblastic Leukemia
- Cabazitaxel in Prostate Cancer: Reduced Dose Noninferior to Standard Dose
- Risk of Some Cancers Higher in Women With a History of Periodontal Disease
- To Better Serve Patients With Cancer, Navigators Need Better Systems
- Physical Activity Improves Cognitive Function for Breast Cancer Survivors
- Risk of Lung Cancer Increases With Diets Higher in Saturated Fats
- Mechanisms Identified for Curcumin Resensitization of Cancer Cells
- Value of Type and Crossmatch Prior to Daratumumab Administration
- Affect of Daratumumab on Laboratory Blood Test Results
- Geriatric Consults Rare in Kidney Cancer Care
- Worse Survival Seen for Alternative Versus Usual Cancer Therapy
- Anorexia-Cachexia in Non-Small Cell Lung Cancer Improved With Anamorelin
- Early Recognition of Checkpoint Inhibitor-Related Pneumonitis Improves Outcomes
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Genitourinary Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Rare Cancers | Regimens | |
| Skin Cancer | Regimens | Drugs |